跳至主要内容
临床试验/NCT01323387
NCT01323387已完成不适用

Lumbar Degenerative Disc Disease Treated With

Synthes USA HQ, Inc.0 个研究点目标入组 178 人开始时间: 2004年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
178
主要终点
Number of Subjects With Successful Radiographic Fusion

研究概览

简要总结

Multi-center, prospective nonrandomized study of treatment for 1 and 2 level degenerative disc disease between L2 and S1. Patients will be followed for a minimum of 2 years.

The primary objective of this study to measure fusion success in patients with lumbar degenerative disc disease using the ATB and ALIF/FRA Spacer. The Secondary objective is evaluation of the patient's quality of life, pain and function.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • One or Two level (consecutive) degenerative disc disease between L2 and S
  • Degenerative disc disease is defined as follows:
  • Chronic pain (confirmed by patient exams and history) of discogenic origin, confirmed by radiographic evidence (e.g. MRI, discogram) two or more of the following:
  • Modic type 2 endplate changes on T2 weighted MRI
  • high intensity zone signal on T2 weighted MRI
  • positive discogram with negative controls
  • dark disc (diminished T2 weighted signal)
  • decreased disc height
  • Has experienced pain, functional deficit and/or neurological deficit for a minimum six month period of time prior to enrollment
  • Has failed to respond to non-operative treatment modalities for a minimum three month period of time prior to enrollment
  • Skeletally mature and at least 18 years of age
  • Signs the approved Informed Consent Document
  • Is available for long term follow-up and interval visits

排除标准

  • Has more than 2 levels to be instrumented
  • Has had a previous fusion attempt at the involved level(s)
  • Has had more than two previous open, lumbar spine surgical procedures at the involved level(s)
  • Currently implanted with anterior instrumentation at the involved level(s)
  • Patient would be classified as morbidly obese BMI > 35
  • Active localized or systemic infection
  • Presence of a disease entity or condition which significantly affects the possibility of bony fusion (e.g., osteoporosis, metastatic cancer, long-term use of steroids, etc.)
  • Has an immunosuppressive disorder
  • Pregnant or interested in becoming pregnant during the study.
  • Has a known sensitivity to device materials
  • Mentally incompetent or prisoner
  • Currently a participant in another study for the same indications.

研究组 & 干预措施

Treatment

Other

Interbody fusions with Anterior Plating

干预措施: Interbody Fusion (Device)

结局指标

主要结局

Number of Subjects With Successful Radiographic Fusion

时间窗: 24 Months

CT Scans and plain film x-rays will be evaluated. Demonstration of bridging trabecular bone through or external to the allograft spacer will be the measure of success.

次要结局

  • Quality of Life Using the SF-12 Scale Physical Health Component Score (PCS). Number of Subjects Who Achieved 15% Improvement in PCS Compared to Baseline.(24 Months)
  • Pain Scores on the Numeric Rating Scale (NRS)(Baseline and 24 Months)
  • Oswestry Disability Index (ODI): Number of Subjects Who Achieved a 15% Improvement in ODI Compared to Baseline(24 Months)
  • Quality of Life Using SF-12 Scale (MCS): Number of Subjects Who Achieved 15% Improvement in MCS Compared to Baseline(Baseline and 24 Months)
  • SF-12 Physical Composite Score (PCS) Summary(Baseline and 24 Months)
  • SF-12 Mental Composite Score (MCS) Summary(Baseline and 24 Months)
  • Oswestry Disability Index (ODI) Summary(Baseline and 24 Months)

研究者

发起方
Synthes USA HQ, Inc.
申办方类型
Industry
责任方
Sponsor

相似试验